Eli Lilly, Novartis Could Pump Close To $3B Into AI Drug Tech
By Gianna Ferrarin · January 8, 2024, 5:31 PM EST
Eli Lilly & Co. and Novartis could invest close to $3 billion in the development of artificial intelligence for drug discovery under two new agreements with a digital biology company owned...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login